Recurrent Glioblastoma Multiforme
DOI:
https://doi.org/10.25077/jka.v9i1S.1176Abstract
Glioblastoma multiforme (GBM) merupakan jenis tumor ganas terbanyak pada otak dengan tingkat rekurensi tinggi mencapai 90%. Penyebab pasti belum diketahui, namun insiden meningkat dengan adanya riwayat glioma dalam keluarga. Diagnosis pasti ditegakkan dengan pemeriksaan histopatologi sel tumor yang ditandai dengan adanya aktivitas mitosis yang tinggi, proliferasi mikrovaskular dan nekrosis. Penatalaksanaan Glioblastoma multiforme melibatkan multidisiplin ilmu, yaitu neuroonkologi, neuropatologi, bedah saraf dan radiasi-onkologi. Penatalaksanaan pasien recurrent GBM yang unresectable adalah dengan kemoterapi sistemik (Temozolomid), radioterapi ulang atau bisa hanya dengan terapi paliatif. Dari beberapa penelitian didapatkan apabila pasien mendapat terapi yang agresif, maka diperkirakan dapat bertahan 14-24 bulan, namun apabila pasien tidak mendapat terapi, maka kemungkinan hanya bertahan selama 4 bulan karena memang prognosis tumor glioma ini sangat buruk.Downloads
Published
How to Cite
Issue
Section
License
Authors retain copyright and grant the Jurnal Kesehatan Andalas right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike (CC BY-SA 4.0) license that allows others to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) the work for any purpose, even commercially with an acknowledgement of the work's authorship and initial publication in Jurnal Kesehatan Andalas.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Jurnal Kesehatan Andalas.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).










